Asher Biotherapeutics
PrivateLast Round
Series C
Apr 16, 2024
Total Funding Raised
$218.15M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Asher Biotherapeutics is a biotechnology company that develops precisely targeted immunotherapies for cancer and other diseases using a proprietary cis-targeting platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Asher Biotherapeutics Comparables
Compare Asher Biotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Synthekine | 91% | |
| Bright Peak Therapeutics | 89% | |
| Inhibrx | 83% |
Asher Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Apr 16, 2024 | ||||
| Series B | Sep 1, 2021 | ||||
| Series A | Mar 23, 2021 | ||||
| Accelerator | Aug 21, 2019 |
Key People
Founding team and executive leadership
Asher Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Janus Henderson Group | Series C, Series B |
| RA Capital Management | Series B, Series C |
| Boxer Capital | Series A, Series C, Series B |
| Invus Opportunities | Series A, Series B |
| Logos Capital | Series B |
| Alexandria Venture Investments | Series B |
| Y Combinator | Series A, Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 31% MoM.
- Apr 16, 2024
$55M round led by RA Capital Management.
Asher Biotherapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Asher Biotherapeutics's valuation, stock price, and market status.
Is Asher Biotherapeutics a public or private company?
Asher Biotherapeutics is a private company.
What is the current stock price of Asher Biotherapeutics?
Asher Biotherapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Asher Biotherapeutics worth (valuation)?
Valuation information for Asher Biotherapeutics is not publicly available.
Can I buy Asher Biotherapeutics stock?
Asher Biotherapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Asher Biotherapeutics's last funding round?
Asher Biotherapeutics's most recent funding round was Series C on April 16, 2024.
Who are the main investors in Asher Biotherapeutics?
Key investors in Asher Biotherapeutics include RA Capital Management, Y Combinator, Wellington Management, Third Rock Ventures.
Will Asher Biotherapeutics IPO soon?
No public IPO plans have been announced for Asher Biotherapeutics.
How can I track Asher Biotherapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Asher Biotherapeutics's secondary market activity and sign up for updates.